Home
PRQR
PRQR News

Latest ProQR Therapeutics N.V. (PRQR) News on June 13, 2025

MT Newswires

a month ago

Oppenheimer Adjusts ProQR Therapeutics N.V Price Target to $9 From $15, Maintains Outperform Rating

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

GlobeNewswire

a month ago

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR)

Simply Wall St.

a month ago

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR)

ProQR Announces First Quarter 2025 Operating and Financial Results

GlobeNewswire

a month ago

ProQR Announces First Quarter 2025 Operating and Financial Results

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

GlobeNewswire

a month ago

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025

GlobeNewswire

a month ago

ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025

ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald

TipRanks

a month ago

ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald

ProQR Therapeutics initiated with an Outperform at Evercore ISI

TipRanks

a month ago

ProQR Therapeutics initiated with an Outperform at Evercore ISI

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

GlobeNewswire

2 months ago

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

ProQR Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

3 months ago

ProQR Therapeutics Full Year 2024 Earnings: Misses Expectations

ProQR Announces Year End 2024 Operating and Financial Results

GlobeNewswire

3 months ago

ProQR Announces Year End 2024 Operating and Financial Results

MT Newswires

3 months ago

Citigroup Upgrades ProQR Therapeutics to Buy From Neutral, Price Target is $4

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) largest shareholders are individual investors with 60% ownership, institutions own 17%

Simply Wall St.

4 months ago

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) largest shareholders are individual investors with 60% ownership, institutions own 17%

Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation?

Simply Wall St.

6 months ago

Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation?

ProQR Therapeutics announces $8.1M in new funding from RSRT

TipRanks

6 months ago

ProQR Therapeutics announces $8.1M in new funding from RSRT

ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration

GlobeNewswire

6 months ago

ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

GlobeNewswire

6 months ago

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

ProQR Therapeutics price target raised to $8 from $5 at JMP Securities

TipRanks

6 months ago

ProQR Therapeutics price target raised to $8 from $5 at JMP Securities

ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024

GlobeNewswire

6 months ago

ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024

ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

ProQR Therapeutics sees cash runway into mid-2027

TipRanks

7 months ago

ProQR Therapeutics sees cash runway into mid-2027

ProQR Announces Third Quarter 2024 Operating and Financial Results

GlobeNewswire

7 months ago

ProQR Announces Third Quarter 2024 Operating and Financial Results

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

GlobeNewswire

8 months ago

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement

GlobeNewswire

8 months ago

ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement

ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares

GlobeNewswire

8 months ago

ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares

Gevo And 2 Other US Penny Stocks To Watch Closely

Simply Wall St.

8 months ago

Gevo And 2 Other US Penny Stocks To Watch Closely

ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year

Simply Wall St.

8 months ago

ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

GlobeNewswire

8 months ago

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

9 months ago

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference

ProQR Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

10 months ago

ProQR Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

ProQR Announces Second Quarter 2024 Operating and Financial Results

GlobeNewswire

10 months ago

ProQR Announces Second Quarter 2024 Operating and Financial Results

Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company

Simply Wall St.

a year ago

Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit

GlobeNewswire

a year ago

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago

ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces First Quarter 2024 Operating and Financial Results

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases

GlobeNewswire

a year ago

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

GlobeNewswire

a year ago

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

GlobeNewswire

a year ago

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

GlobeNewswire

a year ago

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

a year ago

ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations

ProQR Announces Year End 2023 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces Year End 2023 Operating and Financial Results

ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing

GlobeNewswire

a year ago

ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing

LSI Industries Inc. (NASDAQ:LYTS) Q2 2024 Earnings Call Transcript

Insider Monkey

a year ago

LSI Industries Inc. (NASDAQ:LYTS) Q2 2024 Earnings Call Transcript

Keen Vision Acquisition Corporation (NASDAQ:KVAC) most popular amongst retail investors who own 45% of the shares, institutions hold 32%

Simply Wall St.

a year ago

Keen Vision Acquisition Corporation (NASDAQ:KVAC) most popular amongst retail investors who own 45% of the shares, institutions hold 32%

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

GlobeNewswire

a year ago

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most

Simply Wall St.

a year ago

While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

GlobeNewswire

a year ago

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

Is ProQR (PRQR) Stock a Solid Choice Right Now?

Zacks

a year ago

Is ProQR (PRQR) Stock a Solid Choice Right Now?

Is PennantPark Investment (PNNT) Stock Undervalued Right Now?

Zacks

a year ago

Is PennantPark Investment (PNNT) Stock Undervalued Right Now?

Why Intrepid Potash Stock Is Popping This Week

Motley Fool

a year ago

Why Intrepid Potash Stock Is Popping This Week

ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets

GlobeNewswire

2 years ago

ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets

W&T (WTI) Down 13.1% Since Last Earnings Report: Can It Rebound?

Zacks

2 years ago

W&T (WTI) Down 13.1% Since Last Earnings Report: Can It Rebound?

Wall Street Analysts Think Legacy Housing (LEGH) Could Surge 27.38%: Read This Before Placing a Bet

Zacks

2 years ago

Wall Street Analysts Think Legacy Housing (LEGH) Could Surge 27.38%: Read This Before Placing a Bet

5 Small Hidden Gems for the Rest of 2023

Zacks

2 years ago

5 Small Hidden Gems for the Rest of 2023

TRC: Low LA Region Industrial Vacancies, Rising Lease Rates Expected Catalysts for Continued Strong Demand at TRCC

Zacks Small Cap Research

2 years ago

TRC: Low LA Region Industrial Vacancies, Rising Lease Rates Expected Catalysts for Continued Strong Demand at TRCC

Forge Global Holdings, Inc. (NYSE:FRGE) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Forge Global Holdings, Inc. (NYSE:FRGE) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 WEYCO Group Inc Earnings Call

Associated Press Finance

2 years ago

Weyco: Q3 Earnings Snapshot

GlobeNewswire

2 years ago

Weyco Reports Third Quarter Sales and Earnings

ProQR Announces Third Quarter 2023 Operating and Financial Results

GlobeNewswire

2 years ago

ProQR Announces Third Quarter 2023 Operating and Financial Results

Pioneer Closed End Funds Required Notice to Shareholders Sources of Distribution Under Section 19(a)

Business Wire

2 years ago

Pioneer Closed End Funds Required Notice to Shareholders Sources of Distribution Under Section 19(a)

Share on Social Networks: